Brian Patrick O’Neill

Active 1981–2025

76
Papers
20,501
Citations
69
h-index
76
i10-index

Citations

Citations per year for Brian Patrick O’Neill1982: 1 citations1983: 3 citations1984: 5 citations1985: 3 citations1986: 6 citations1987: 3 citations1988: 2 citations1989: 5 citations1990: 6 citations1991: 5 citations1992: 16 citations1993: 6 citations1994: 9 citations1995: 15 citations1996: 9 citations1997: 13 citations1998: 9 citations1999: 36 citations2000: 28 citations2001: 22 citations2002: 29 citations2003: 38 citations2004: 54 citations2005: 49 citations2006: 71 citations2007: 63 citations2008: 81 citations2009: 54 citations2010: 85 citations2011: 92 citations2012: 111 citations2013: 90 citations2014: 175 citations2015: 254 citations2016: 242 citations2017: 280 citations2018: 245 citations2019: 788 citations2020: 771 citations2021: 716 citations2022: 555 citations2023: 373 citations2024: 516 citations2025: 218 citations2026: 10 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,693 citing papers, 30.7% of this breakdownChina: 904 citing papers, 10.3% of this breakdownGermany: 590 citing papers, 6.7% of this breakdownUnited Kingdom: 451 citing papers, 5.1% of this breakdownItaly: 377 citing papers, 4.3% of this breakdownFrance: 334 citing papers, 3.8% of this breakdownCanada: 306 citing papers, 3.5% of this breakdownNetherlands: 298 citing papers, 3.4% of this breakdownSwitzerland: 233 citing papers, 2.7% of this breakdownJapan: 215 citing papers, 2.5% of this breakdownSpain: 206 citing papers, 2.3% of this breakdownAustralia: 195 citing papers, 2.2% of this breakdown
0%30.7%Other 22.5%

Fields

  • Medicine67%
  • Biochemistry, Genetics and Molecular Biology24.3%
  • Immunology and Microbiology2.7%
  • Neuroscience2.5%
  • Engineering0.8%
  • Computer Science0.6%
  • Other2.1%

Topics

  • Glioma Diagnosis and Treatment17.7%
  • Brain Metastases and Treatment3.8%
  • CNS Lymphoma Diagnosis and Treatment3.4%
  • Lymphoma Diagnosis and Treatment3.2%
  • Cancer Genomics and Diagnostics2.8%
  • Radiomics and Machine Learning in Medical Imaging2.5%
  • Other66.6%

Coauthors

All papers

Open in search
  1. The Somatic Genomic Landscape of Glioblastoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jennifer Eschbacher, Gaetano Finocchiaro, William A. Friedman, David W. Andrews, Abhijit Guha, Mary Iacocca, Brian Patrick O’Neill, Greg Foltz, Jerome Myers, Daniel J. Weisenberger, Robert Penny, Raju Kucherlapati, Charles M. Perou, D. Neil Hayes, Richard A. Gibbs, Marco A. Marra, Gordon B. Mills, Eric S. Lander, Paul T. Spellman, Richard K. Wilson, Chris Sander, John N. Weinstein, Matthew Meyerson, Stacey Gabriel, Peter W. Laird, David Haussler, Gad Getz, Lynda Chin, Christopher C. Benz, Jill S. Barnholtz‐Sloan, Wendi Barrett, Quinn T. Ostrom, Yingli Wolinsky, Keith L. Black, Bikash Bose, Paul T. Boulos, Madgy Boulos, Jenn Brown, Christine Czerinski, Matthew Eppley, Mary Iacocca, Thelma Kempista, Teresa Kitko, Yakov Koyfman, Brenda Rabeno, Pawan Rastogi, Michael C. Sugarman, Patricia Swanson, Kennedy Yalamanchii, Ilana P. Otey, Yingchun Spring Liu, Yonghong Xiao, J. Todd Auman, Peng‐Chieh Chen, Angela Hadjipanayis, Eunjung Lee, Semin Lee, Peter J. Park, Jonathan G. Seidman, Lixing Yang, Raju Kucherlapati, Steven N. Kalkanis, Tom Mikkelsen, Laila Poisson, Aditya Raghunathan, Lisa Scarpace, Brady Bernard, Ryan Bressler, Andrea Eakin, Lisa Iype and 200 more - Cell 2013 cited by 5,227

  2. Glioma Groups Based on 1p/19q,IDH, andTERTPromoter Mutations in Tumors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Susan M. Chang, Michael D. Prados, Joseph L. Wiemels, John K. Wiencke, Margaret Wrensch, Robert B. Jenkins - New England Journal of Medicine 2015 cited by 1,984

  3. Genomic and Phenotypic Characterization of a Broad Panel of Patient-Derived Xenografts Reflects the Diversity of Glioblastoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Caterina Giannini, Robert B. Jenkins, Ian F. Parney, Jann N. Sarkaria - Clinical Cancer Research 2019 cited by 239

  4. Report of an International Workshop to Standardize Baseline Evaluation and Response Criteria for Primary CNS Lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2005 cited by 906

  5. Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Carys Morgan, Simon L. Parsons, Neel Bhuva, Sorcha Campbell, Liam Grogan, Greg Leonard, Andrew Bateman, Catherine Mitchell, Séamus O’Reilly, Eibhlin Mulroe, Olivia McLoughlin, Anna Shevlin, Aoife M. Shannon, Jacinta Marron, Marc Nolan, Grace Burch, Michelle Costello, Daniel E. Griffiths, Kelly Cozens, Emma Foley, Claire L. Donohoe, Catherine O’Farrell, Jennifer E. Moore, Jacintha O’Sullivan - ˜The œLancet. Gastroenterology & hepatology 2023 cited by 173

  6. Radiogenomics to characterize regional genetic heterogeneity in glioblastoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Neuro-Oncology 2016 cited by 226

  7. Glioblastoma survival in the United States before and during the temozolomide era

    Authors: , - Journal of Neuro-Oncology 2011 cited by 729

  8. Systemic immune suppression in glioblastoma: the interplay between CD14+HLA-DRlo/neg monocytes, tumor factors, and dexamethasone

    Authors: , , , , , , - Neuro-Oncology 2010 cited by 235

  9. Quality of Life After Transcatheter Tricuspid Valve Replacement

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David J. Cohen - Journal of the American College of Cardiology 2024 cited by 73

  10. Prospective Randomized Trial of Low- Versus High-Dose Radiation Therapy in Adults With Supratentorial Low-Grade Glioma: Initial Report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group Study

    Authors: , , , , , , , , , , , , , , - Journal of Clinical Oncology 2002 cited by 730

  11. Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas

    Authors: , , , , , , , , , , , , , , , , - Clinical Cancer Research 2015 cited by 218

  12. A clinical review of treatment outcomes in glioblastoma multiforme—the validation in a non-trial population of the results of a randomised Phase III clinical trial: has a more radical approach improved survival?

    Authors: , , , , , , - British Journal of Radiology 2012 cited by 202

  13. Phase 1 study of pomalidomide and dexamethasone for relapsed/refractory primary CNS or vitreoretinal lymphoma

    Authors: , , , , , , , , , , , , , - Blood 2018 cited by 133

  14. Multi-Parametric MRI and Texture Analysis to Visualize Spatial Histologic Heterogeneity and Tumor Extent in Glioblastoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - PLoS ONE 2015 cited by 129

  15. First-line treatment and outcome of elderly patients with primary central nervous system lymphoma (PCNSL)—a systematic review and individual patient data meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Annals of Oncology 2015 cited by 189

  16. Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Genetics 2009 cited by 513

  17. Central Nervous System Tumors

    Authors: , , , , , - Mayo Clinic Proceedings 2007 cited by 339

  18. Pivotal Clinical Study to Evaluate the Safety and Effectiveness of the MANTA Percutaneous Vascular Closure Device

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert M. Bersin, Ming Zhang, Srinivasa Potluri, Colin M. Barker, Nelson L. Bernardo, Alan B. Lumsden, Andrew Barleben, John Campbell, David J. Cohen, Michael D. Dake, David L. Brown, Nathaniel Maor, Samuel Nardone, Sandra Lauck, William W. O’Neill, John G. Webb, on behalf of the SAFE MANTA Study Investigators - Circulation Cardiovascular Interventions 2019 cited by 120

  19. Adrenoleukodystrophy

    Authors: , , , , , , - Neurology 1981 cited by 397

  20. Gliomas in Neurofibromatosis Type 1: A Clinicopathologic Study of 100 Patients

    Authors: , , , , , , - Journal of Neuropathology & Experimental Neurology 2008 cited by 188

  21. Synergistic Effects of the Combination of Alpelisib (PI3K Inhibitor) and Ribociclib (CDK4/6 Inhibitor) in Preclinical Colorectal Cancer Models

    Authors: , , , , , , , , , - International Journal of Molecular Sciences 2024 cited by 11

  22. A germline variant in the TP53 polyadenylation signal confers cancer susceptibility

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Fernando Rivera, Dolores Planelles, Vincent Soriano, Celia Requena, Katja K.H. Aben, Michelle M. van Rossum, R.G.H.M. Cremers, Inge M. van Oort, Dick-Johan van Spronsen, Jack A. Schalken, Wilbert H.M. Peters, Brian T. Helfand, Jenny Donovan, Freddie C. Hamdy, D. Badescu, O. Codreanu, Mariana Jinga, Irma Eva Csiki, Vali Constantinescu, P Badea, Ioan Nicolae Mateș, Daniela Dinu, Adrian Constantin, Dana Mateș, Sjöfn Kristjánsdóttir, Bjarni A. Agnarsson, Eiríkur Jónsson, Rósa B. Barkardóttir, Guðmundur Einarsson, Fridbjörn Sigurdsson, Páll Helgi Möller, Tryggvi Stefánsson, Trausti Valdimarsson, Oskar T. Johannsson, Helgi Sigurðsson, Þorvaldur Jónsson, Jón G. Jónasson, Laufey Tryggvadóttír, Terri Rice, Helen M. Hansen, Yuanyuan Xiao, Daniel H. Lachance, Brian Patrick O’Neill, Matthew Kosel, Paul A. Decker, Guðmar Þorleifsson, Hrefna Johannsdottir, Hafdís T. Helgadóttir, Ásgeir Sigurðsson, Valgerður Steinthórsdóttir, Annika Lindblom, Robert S. Sandler, Temitope O. Keku, Karina Banasik, Torben Jørgensen, Daniel R. Witte, Torben Hansen, Oluf Pedersen, Viorel Jinga, David E. Neal, William J. Catàlona, Margaret Wrensch, John K. Wiencke, Robert B. Jenkins, Eduardo Nagore, Ulla Vogel, Lambertus A. Kiemeney, Rajiv Kumar, José Mayordomo, Jón Ólafsson and 4 more - Nature Genetics 2011 cited by 304

  23. Immunomodulatory treatment trial for paraneoplastic neurologicaldisorders

    Authors: , , , , - Neuro-Oncology 2004 cited by 217

  24. The changing incidence of primary central nervous system lymphoma is driven primarily by the changing incidence in young and middle‐aged men and differs from time trends in systemic diffuse large B‐cell non‐Hodgkin's lymphoma

    Authors: , , , - American Journal of Hematology 2013 cited by 146